Sichenzia Ross Ference LLP Represents AIT Therapeutics, Inc. in $20,000,000 Line of Credit

AIT therapeutics

Press Release – New York, NY – September 5, 2018 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (OTC: “AITB”) in a common stock purchase agreement with Lincoln Park Capital Fund, LLC a Chicago-based institutional investor. On September 4, 2018, pursuant to the common stock purchase agreement AIT sold Lincoln Park $526,500 of its unregistered shares of common stock at a price of $4.50 per share.  The Company may subject to an effective registration statement sell Lincoln Park an additional $19,473,500 shares of common stock over a 36-month period at the prices set forth in the common stock purchase agreement. The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Avital Perlman, David Manno and Counsel, Kimberly Boler.